Related Experiment Video

Updated: Jan 22, 2026

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent
06:46

Non-invasive In Vivo Fluorescence Optical Imaging of Inflammatory MMP Activity Using an Activatable Fluorescent Imaging Agent

Published on: May 8, 2017

9.3K

Immunoexpression of MMP-8, MMP-9 and TIMP-2 in dilated cardiomyopathy

Radu Mitruţ1, Alex Emilian Stepan, Claudiu Mărgăritescu

  • 1Department of Pathology, University of Medicine and Pharmacy of Craiova, Romania; astepan76@yahoo.com.

Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie
|July 3, 2019
PubMed

Insights

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are key in dilated cardiomyopathy (DCM). Their altered expression impacts extracellular matrix remodeling, offering potential therapeutic targets.

Area of Science:

  • Cardiovascular Biology
  • Molecular Pathology
  • Biochemistry

Background:

  • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play crucial roles in extracellular matrix (ECM) remodeling.
  • Alterations in MMPs and TIMPs expression are implicated in various cardiac diseases, including dilated cardiomyopathy (DCM).
  • These proteins are significant as potential surrogate markers for ECM remodeling in DCM.

Purpose of the Study:

  • To investigate the immunoexpression of MMP-8, MMP-9, and TIMP-2 in the hearts of DCM patients.
  • To correlate the expression levels of these proteins with a histological composite score (HCS) in DCM.

Main Methods:

  • Analysis of 40 DCM patient heart fragments using standard paraffin embedding techniques.
  • Semi-quantitative evaluation of histopathological parameters to establish a HCS.
  • Immunohistochemical processing for MMP-8, MMP-9, and TIMP-2, followed by semi-quantitative intensity assessment.

Main Results:

  • MMP-8 was exclusively found in myocardiocytes; MMP-9 and TIMP-2 were present in both myocardiocytes and stroma with varying intensities.
  • Increased MMP-8 and TIMP-2 immunoreaction intensity correlated significantly with a lower HCS.
  • Elevated MMP-9 intensity showed an association with a lower HCS, though the overall difference was not statistically significant.

Conclusions:

  • An imbalance between TIMPs and MMPs contributes to ECM disruption and cardiac remodeling in DCM.
  • These findings highlight the potential of targeting MMP-TIMP interactions for novel clinical therapies in DCM.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.3K
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

13.9K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
492
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
488
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
433
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
521
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
321
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
361